1/32
Flashcards about the molecular basis of genetic disease.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Define Molecular Disease
Disorders caused by a change affecting a gene, its structure, and/or its expression, which changes the amount or function of the gene product.
Define Biochemical Genetics
The study of phenotype at the level of proteins, biochemistry, and metabolism.
Mutations can affect protein function. Define the 4 ways?
Loss of function mutation
Gain of function mutations
Novel property mutations
Mutations associated with heterochronic or ectopic gene expression
Loss of function mutation - no functional gene product at all
Gain of function mutations - too much gene product
Novel property mutations - specific type of missense causing protein to gain a new function or abnormal function
Mutations associated with heterochronic or ectopic gene expression
heterochronic = time of gene expression is inappropriate
Ectopic = gene is in the wrong place such as a specific tissue and the tissue is not supposed to express gene there (hair on eyes)
Describe loss of function mutations
most common by far
for protein coding
severity of disease depends on how much function is lost
ex: Alpha Thalassemia (deletion), Turner Syndrome, Retinoblastoma, Beta thalassemias (may affect RNA splicing)
Describe Gain of function mutations
can increase production of a normal protein
Ex: Down Syndrome, 1 form of Familial Alzheimers, Charcot marie tooth disease type 1A
Can enhance normal function of protein
ex: hemoglobin kempsey
commonly due to gene dosage (duplication)
What is the result of mutations in the coding region of proteins?
Structurally abnormal proteins may lead to a loss or gain of function or novel property that causes disease.
What can mutations in regulatory elements alter?
Can alter the abundance of mRNA or the time or cell type in which the gene is expressed.
Give an example of a novel property mutation
Sickle cell disease; caused by an amino acid substitution that doesn't interfere with its ability to transport oxygen, but the new property is the polymerization that deforms the red blood cell.
Where do heterochronic and ectopic mutations take place?
Mutations in the regulatory regions of a gene.
What are the eight steps at which mutations can disrupt the production of a normal protein?
Transcription, translation, polypeptide folding, post-translational modification, assembly of monomers, subcellular localization, cofactor binding, and protein function.
What are the three genetic causes for variation in clinical phenotype observed in an inherited disease?
Allelic heterogeneity, locus heterogeneity, and the effect of modifier genes.
Allelic Heterogeneity vs Locus Heterogeneity
Allelic heterogenetiy - different mutations in the same gene cause the same disease (2 mutations > same disease)
Locus heterogeneity - mutations at different genes, cause same disease or phenotype (2 genes > same mutation)
______ is due to presence of multiple alleles at a single locus
allelic heterogeneity
Null Allele
A completely non-functional allele.
form of allelic heterogeneity
Locus Heterogeneity
Mutations in more than one locus result in a specific condition.
ex: thalassemia
Effects of Modifier Genes
Variation in phenotype results from the effects of one gene on another.
they do not cause the disease direclty but modify how mild or severe the condition appears
ex: beta-thalassemia homozygotes with alapha thalassemia variant
______ are the most common single-gene disorders
Hemoglobinopathies
ex: normal adult hemoglobin (Hb A)
Describe the structure of a Normal Adult Hemoglobin (Hb A)
Two α-globin and two beta-globin peptides
There are 5 other normal Hbg (compared to Hb A) and they are made up of ______ and ______.
Which one is located on chromosome 16?
Which one is found on chromosome 11?
2 alpha like chains and 2 non-alpha like chains
Genes for the alpha and alpha-like chains (2 identical alpha genes)
Beta and beta-like globlin (globulin is a type of protein that binds oxygen
Define Globin Switching
Process of expression of various globin genes change during development (occurs in alpha and beta)
Hgb F (in beta family) predominate during fetal life but by 3 months age, child has almost all Hb A
The locus of the locus control region plays an epigenetic role, how?
Creates an open chromatin configuration allowing transcription factors access to regulatory elements
Active Chromatin Hub
Beta-Globin Locus Control Region (LCR)
Each of the five regions of open chromatin contains several consensus binding sites for both erythroid-specific and ubiquitous transcription factors.
Clinical Significance of the LCR
Failure to express the genes of the beta-globin cluster. 2. Likely an Important target for gene therapy in related diseases. 3. Understanding the molecular mechanism of globin switching may allow increased expression of gamma-globin for beta-thalassemia.
Mechanism of Sickle Cell Disease
Polymerization of deoxygenated sickle hemoglobin (HbS), resulting in a deformity of the red blood cell and a marked decrease in its ability to pass through the microvasculature.
Modifier Genes and Sickle Cell Disease
Higher levels of Hgb F (2 alpha, 2 gamma) create less severe disease because Hgb F is an effective 02 carrier and inhibits polymer formation of Hgb S.
Variants with Altered Oxygen Transport
Oxygen binding and release is impaired, but other properties generally remain intact, with minimal effect on Hgb stability.
Hb Kempsey
The mutation locks the Hgb into the high-affinity state, so it won't release the 02 to the tissues, resulting in polycythemia.
What is the Pathophysiological Effect of Hb Hammersmith
An unstable Hb leading to Hb precipitation and hemolysis and also low oxygen affinity.
What is the Pathophysiological Effect of Hb Hyde Park
The substitution makes oxidized heme iron resistant to methemoglobin reductase, cyanosis (asymptomatic).
Thalassemia
Cause by a reduction in the synthesis/stability of alpha or beta globin chains with the excess chains precipitate and damage the RBC membrane, causing hemolysis.
Alpha-Thalassemias
Reduction in the synthesis/stability of alpha globin chains.
Beta-Thalassemias
Reduction in the synthesis/stability of beta globin chains.